Topic: GLAXOSMITHKLINE
47 results were found.
GlaxoSmithKline Q1 profit climbs - April 27, 2022
GlaxoSmithKline to buy Sierra Oncology for $1.9 billion - April 13, 2022
GlaxoSmithKline FY21 fiscal 2021 adjusted operating profit 8.81 billion pounds - February 9, 2022
GlaxoSmithKline wins $945.11m Army contract - January 13, 2022
GlaxoSmithKline and Vir Biotechnology's monoclonal antibody treatment XEVUD for COVID-19 approved - December 8, 2021
GlaxoSmithKline Q2 sales up 10% - October 27, 2021
GlaxoSmithKline unveils plan for UK headquarters of new Consumer Healthcare company - October 11, 2021
GlaxoSmithKline: Second generation mRNA COVID-19 vaccine candidate demonstrates improved immune response - August 16, 2021
GlaxoSmithKline Q2 profit down 44 percent - July 28, 2021
GlaxoSmithKline encourages holders to reject TRC Capital mini-tender offer - June 5, 2021
Sanofi and GlaxoSmithKline COVID-19 vaccine sees up to 100% efficacy - May 17, 2021
GlaxoSmithKline Q1 operating profit down 23% - April 29, 2021
GlaxoSmithKline profit to shareholders increased to 5.75 billion - February 4, 2021
GlaxoSmithKline Q3 pretax profit 1.67 billion pounds - October 28, 2020
GlaxoSmithKline Q2 profit more than doubles - July 29, 2020
GlaxoSmithKline FY19 profit rises - February 5, 2020
GlaxoSmithKline Q3 profit rises - October 30, 2019
Commission approves GlaxoSmithKline's acquisition of Pfizer's Consumer Health Business - July 10, 2019
GlaxoSmithKline and Merck KGaA strike deal worth up to $4 billion - February 6, 2019
GlaxoSmithKline non-executive chairman Sir Philip Hampton to step down - January 21, 2019
GlaxoSmithKline and Pfizer to form consumer healthcare joint venture - December 19, 2018
GlaxoSmithKline Q1 net income fell 48 percent - April 25, 2018
GlaxoSmithKline calls for transition period as Amsterdam wins race for EMA - November 21, 2017
GlaxoSmithKline appoints Hal Barron as CSO - November 9, 2017
GlaxoSmithKline Q3 profit up 34 percent - October 25, 2017
GlaxoSmithKline awarded $235 million in U.S. generic drug case - June 22, 2017
GlaxoSmithKline profit nearly quadrupled - April 26, 2017
GlaxoSmithKline swings to profit thanks to weak pound - February 8, 2017
GlaxoSmithKline: Luke Miels appointed president, global pharmaceuticals - January 20, 2017
GlaxoSmithKline to pay $20m to settle bribery charges - September 30, 2016
GlaxoSmithKline names Emma Walmsley as next CEO - September 20, 2016
GlaxoSmithKline to drop patents in world's poorest countries - March 31, 2016
GlaxoSmithKline CEO Sir Andrew Witty to retire in 2017 - March 18, 2016
UK competition authorities fine GlaxoSmithKline $54.5 million - February 12, 2016
GlaxoSmithKline appoints Jesse Goodman as director - December 24, 2015
GlaxoSmithKline plans 20 new drugs for regulatory approval - November 5, 2015
GlaxoSmithKline Q3 sales increase 9% to 6.13 billion - October 29, 2015
GlaxoSmithKline net profit decreased 77% - July 29, 2015
Another class action lawsuit against GlaxoSmithKline and Zofran - June 15, 2015
GlaxoSmithKline appoints Manvinder Singh as non-executive director - May 8, 2015
GlaxoSmithKline chairman Christopher Gent to step down - February 27, 2015
GlaxoSmithKline appoints Urs Rohner as director - October 6, 2014
GlaxoSmithKline appoints Sir Philip Hampton to the board - September 25, 2014
GlaxoSmithKline appoints Hans Wijers as non-executive director - January 25, 2013
GlaxoSmithKline' director Sir Robert Wilson to stay until 2014 - September 27, 2012
GlaxoSmithKline realignes regions, changes executive team - April 30, 2008
GlaxoSmithKline: Eddie Gray is coming - December 8, 2007